Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SHE:002317)
China flag China · Delayed Price · Currency is CNY
21.84
+0.03 (0.14%)
Jun 9, 2026, 3:04 PM CST

SHE:002317 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
737.08985.41,3991,252927.671,016
Short-Term Investments
377.56221.38163.69389.1151.7540
Trading Asset Securities
390.38103.66305.99683.06340.68239.92
Cash & Short-Term Investments
1,5051,3101,8692,3241,4201,296
Cash Growth
10.60%-29.89%-19.58%63.66%9.55%-20.49%
Accounts Receivable
1,4131,222999.6978.31,204792.46
Other Receivables
6.9449.4855.8545.6229.4411.48
Receivables
1,4201,2711,0551,0241,233803.94
Inventory
354.02365.3441.48520.39481.06452.2
Prepaid Expenses
-----0
Other Current Assets
151.5896.4996.7492.1100.4119.12
Total Current Assets
3,4313,0443,4633,9613,2352,672
Property, Plant & Equipment
782.77802.14687.36695.91636.82601.24
Long-Term Investments
140.65299.33516.23519.95727.09650.61
Goodwill
6.956.956.95208.63208.63208.63
Other Intangible Assets
488.93503.71327.11446.7260.4261.28
Long-Term Deferred Tax Assets
16.2520.5729.6942.4547.0346.89
Long-Term Deferred Charges
437.44435.2489.91564.31586.61401.03
Other Long-Term Assets
38.191833.4419.9774.1560.76
Total Assets
5,3425,1305,5536,4595,7754,902
Accounts Payable
118.81117.9693.193.78126.28106.7
Accrued Expenses
19.43165.76141.86163.32232.01164.43
Short-Term Debt
287.73318.52303.46621.49587.6190
Current Portion of Long-Term Debt
---2.092212
Current Portion of Leases
1.931.741.662.722.551.71
Current Income Taxes Payable
38.542.814.9212.4613.611.51
Current Unearned Revenue
210.620.620.0825.9145.2418.85
Other Current Liabilities
152.5590.93638.3993.5479.0429
Total Current Liabilities
829.58718.321,2031,0151,108524.2
Long-Term Debt
---97286308
Long-Term Leases
5.646.040.31.34.025.27
Long-Term Unearned Revenue
196.4202.05161.94132.6755.5732.74
Long-Term Deferred Tax Liabilities
48.2841.2738.948.9570.2359.96
Other Long-Term Liabilities
11.9212.03138.76637.61434.68433.67
Total Liabilities
1,092979.711,5431,9331,9591,364
Common Stock
849.93849.93851.56853.35814.43814.46
Additional Paid-In Capital
1,8191,8161,7801,8071,3101,321
Retained Earnings
1,4421,3421,2371,7061,6041,444
Treasury Stock
---8.1-67.14-80.36-151.6
Comprehensive Income & Other
49.0449.5154.8657.3654.4547.52
Total Common Equity
4,1604,0583,9154,3563,7033,476
Minority Interest
89.7991.6895.34169.37113.7262.49
Shareholders' Equity
4,2504,1504,0104,5263,8163,538
Total Liabilities & Equity
5,3425,1305,5536,4595,7754,902
Total Debt
295.3326.3305.43724.6902.17516.98
Net Cash (Debt)
1,210984.141,5641,600517.93779.3
Net Cash Growth
20.11%-37.06%-2.24%208.85%-33.54%-14.76%
Net Cash Per Share
1.451.181.881.940.640.98
Filing Date Shares Outstanding
849.93849.93846.01847.8808.88797.43
Total Common Shares Outstanding
849.93849.93846.01847.8808.88797.43
Working Capital
2,6012,3252,2592,9452,1262,147
Book Value Per Share
4.894.774.635.144.584.36
Tangible Book Value
3,6643,5483,5813,7013,2343,006
Tangible Book Value Per Share
4.314.174.234.374.003.77
Buildings
-573.53561.69527.39506.28474.51
Machinery
-763.36734.13638.4600.95568.8
Construction In Progress
-151.3127.58123.5582.0356.47